By expenditures
| Name | Title | Type |
|---|---|---|
| Michelle Rebollosa | Chief Financial Officer | Auditee |
| Anthony Madera | CHIEF FINANCIAL OFFICER | Auditee |
| Shane Cox | Partner | Auditee |
| No contacts on file | ||
| ID | Year | Date Accepted | Auditor | Spend |
|---|---|---|---|---|
| 370042 | 2024 | 2025-09-30 | Stauffer & Associates PLLC | $90.56M |
| 323095 | 2023 | 2024-09-30 | Stauffer & Associates PLLC | $76.11M |
| 37362 | 2022 | 2023-09-28 | Stauffer & Associates PLLC | $69.68M |
| Audit | Year | Accepted | Finding | Ref | Severity | Repeat | Requirement |
|---|---|---|---|---|---|---|---|
| 370042 | 2024 | 2025-09-30 | 1158110 | 2024-006 | Material Weakness | Yes | H |
| 370042 | 2024 | 2025-09-30 | 1158109 | 2024-006 | Material Weakness | Yes | H |
| 370042 | 2024 | 2025-09-30 | 1158108 | 2024-006 | Material Weakness | Yes | H |
| 370042 | 2024 | 2025-09-30 | 1158107 | 2024-006 | Material Weakness | Yes | H |
| 370042 | 2024 | 2025-09-30 | 1158106 | 2024-005 | Material Weakness | Yes | G |
| 370042 | 2024 | 2025-09-30 | 1158105 | 2024-005 | Material Weakness | Yes | G |
| 370042 | 2024 | 2025-09-30 | 1158104 | 2024-005 | Material Weakness | Yes | G |
| 370042 | 2024 | 2025-09-30 | 1158103 | 2024-005 | Material Weakness | Yes | G |
| 370042 | 2024 | 2025-09-30 | 1158102 | 2024-004 | Material Weakness | Yes | L |
| 370042 | 2024 | 2025-09-30 | 1158101 | 2024-004 | Material Weakness | Yes | L |
| 370042 | 2024 | 2025-09-30 | 1158100 | 2024-004 | Material Weakness | Yes | L |
| 370042 | 2024 | 2025-09-30 | 1158099 | 2024-004 | Material Weakness | Yes | L |
| 370042 | 2024 | 2025-09-30 | 1158098 | 2024-003 | Material Weakness | Yes | I |
| 370042 | 2024 | 2025-09-30 | 1158097 | 2024-002 | Material Weakness | Yes | F |
| 370042 | 2024 | 2025-09-30 | 1158096 | 2024-002 | Material Weakness | Yes | F |
| 370042 | 2024 | 2025-09-30 | 1158095 | 2024-002 | Material Weakness | Yes | F |
| 323095 | 2023 | 2024-09-30 | 1076771 | 2023-004 | Significant Deficiency | - | F |
| 323095 | 2023 | 2024-09-30 | 1076770 | 2023-004 | Significant Deficiency | - | F |
| 323095 | 2023 | 2024-09-30 | 1076769 | 2023-003 | Significant Deficiency | - | E |
| 323095 | 2023 | 2024-09-30 | 1076768 | 2023-003 | Significant Deficiency | - | E |
| 323095 | 2023 | 2024-09-30 | 1076767 | 2023-002 | Material Weakness | - | AB |
| 323095 | 2023 | 2024-09-30 | 1076766 | 2023-002 | Material Weakness | - | AB |
| 323095 | 2023 | 2024-09-30 | 500329 | 2023-004 | Significant Deficiency | - | F |
| 323095 | 2023 | 2024-09-30 | 500328 | 2023-004 | Significant Deficiency | - | F |
| 323095 | 2023 | 2024-09-30 | 500327 | 2023-003 | Significant Deficiency | - | E |
| 323095 | 2023 | 2024-09-30 | 500326 | 2023-003 | Significant Deficiency | - | E |
| 323095 | 2023 | 2024-09-30 | 500325 | 2023-002 | Material Weakness | - | AB |
| 323095 | 2023 | 2024-09-30 | 500324 | 2023-002 | Material Weakness | - | AB |
| 37362 | 2022 | 2023-09-28 | 617869 | 2022-002 | Material Weakness | - | I |
| 37362 | 2022 | 2023-09-28 | 617868 | 2022-002 | Material Weakness | - | I |
| 37362 | 2022 | 2023-09-28 | 41427 | 2022-002 | Material Weakness | - | I |
| 37362 | 2022 | 2023-09-28 | 41426 | 2022-002 | Material Weakness | - | I |